US EditionPublished • loading... • Updated
INVESTOR DEADLINE: Soleno Therapeutics Inc. (SLNO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - Soleno Therapeutics (NASDAQ:SLNO)
Robbins Geller seeks lead plaintiff for a class action alleging Soleno hid serious DCCR safety issues, causing a 27% stock drop after a critical short-seller report, firm said.
Summary
1 Articles
1 Articles
BSX INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - Boston Scientific (NYSE:BSX)
SAN DIEGO, March 22, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE:BSX) common stock between July 23, 2025 and February 3, 2026, both dates inclusive (the "Class Period"), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scientific class action lawsuit. Captioned Troike v. Boston Scientific Corporation, No. 26-cv-40…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
